par Meraviglia, S;Eberl, M;Vermijlen, David 
;Todaro, M;Buccheri, S;Cicero, G;La Mendola, C;Guggino, G;D'Asaro, M;Orlando, V;Scarpa, F;Roberts, Allen;Caccamo, N;Stassi, G;Dieli, F;Hayday, A C
Référence Clinical and experimental immunology, 161, 2, page (290-297)
Publication Publié, 2010-08
;Todaro, M;Buccheri, S;Cicero, G;La Mendola, C;Guggino, G;D'Asaro, M;Orlando, V;Scarpa, F;Roberts, Allen;Caccamo, N;Stassi, G;Dieli, F;Hayday, A CRéférence Clinical and experimental immunology, 161, 2, page (290-297)
Publication Publié, 2010-08
Article révisé par les pairs
| Titre: |
|
| Auteur: | Meraviglia, S; Eberl, M; Vermijlen, David; Todaro, M; Buccheri, S; Cicero, G; La Mendola, C; Guggino, G; D'Asaro, M; Orlando, V; Scarpa, F; Roberts, Allen; Caccamo, N; Stassi, G; Dieli, F; Hayday, A C |
| Informations sur la publication: | Clinical and experimental immunology, 161, 2, page (290-297) |
| Statut de publication: | Publié, 2010-08 |
| Sujet CREF: | Immunologie |
| Mots-clés: | cytokines |
| cytotoxicity | |
| immunotherapy | |
| metastatic breast cancer | |
| Vγ9Vδ2 T cells | |
| MeSH keywords: | Adjuvants, Immunologic -- adverse effects -- pharmacology -- therapeutic use |
| Aged | |
| Antigens, CD27 -- metabolism | |
| Antigens, CD45 -- metabolism | |
| Breast Neoplasms -- blood -- immunology -- therapy | |
| Cell Proliferation -- drug effects | |
| Chemokines -- blood | |
| Cytokines -- blood | |
| Diphosphonates -- adverse effects -- pharmacology -- therapeutic use | |
| Disease Progression | |
| Esterases -- metabolism | |
| Female | |
| Hemiterpenes -- pharmacology | |
| Humans | |
| Imidazoles -- adverse effects -- pharmacology -- therapeutic use | |
| Immunotherapy -- methods | |
| Interferon-gamma -- metabolism | |
| Interleukin-2 -- adverse effects -- pharmacology -- therapeutic use | |
| Lymphocyte Activation -- drug effects | |
| Lymphocyte Count | |
| Lysine -- analogs & derivatives -- metabolism | |
| Middle Aged | |
| Mucin-1 -- blood | |
| Organophosphorus Compounds -- pharmacology | |
| Receptors, Antigen, T-Cell, gamma-delta -- metabolism | |
| Remission Induction | |
| Salvage Therapy | |
| T-Lymphocyte Subsets -- cytology -- drug effects -- immunology -- metabolism | |
| TNF-Related Apoptosis-Inducing Ligand -- metabolism | |
| Treatment Outcome | |
| Note générale: | Clinical Trial, Phase I |
| Journal Article | |
| Research Support, Non-U.S. Gov't | |
| FLWIN | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0009-9104 |
| info:doi/10.1111/j.1365-2249.2010.04167.x | |
| info:pii/CEI4167 | |
| info:scp/77954652637 | |
| info:pmid/20491785 | |
| PMC2909411 |
